Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Carrick Therapeutics
Research
Syros targets KRAS-mutant cancer with CDK7 inhibitor
The combination of SY-5609 and gemcitabine showed near-complete tumor inhibition in mice with xenografts of KRAS-G12D pancreatic tumors.
Angus Liu
Sep 20, 2021 11:30am
A new approach to resistant prostate cancer
Aug 29, 2019 9:00am
Carrick hires ex-Tesaro CFO, shifts focus toward U.S.
Jun 28, 2019 10:16am
